Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Rees

Showing results (21-30 of 134) with videos related to

Pageof 14
Sort By:
BJU International|April 18, 2015
Patients not P valuesJonathan Rees
The Practitioner|March 3, 2015
DRE has vital role in early detection of prostate cancerJonathan Rees
The Practitioner|October 12, 2017
Does testosterone therapy raise the risk of VTE?Jonathan Rees
The Practitioner|October 11, 2017
Active monitoring vs treatment for localised prostate cancerJonathan Rees
Plos Medicine|April 21, 2005
The problem with academic medicine: engineering our way into and out of the messJonathan Rees
The Practitioner|November 24, 2015
Androgen deprivation therapy and cardiovascular riskJonathan Rees
Lancet (London, England)|September 21, 2002
Functional polymorphism in EGF gene and malignant melanomaJonathan Rees
The Practitioner|August 3, 2013
No place for routine urine cytology in haematuriaJonathan Rees
The Practitioner|January 22, 2015
Obesity, metformin and prostate cancer riskJonathan Rees
The Practitioner|January 4, 2014
PSA in men in their 40s predicts risk of prostate cancer deathJonathan Rees
Pageof 14

Showing results (21-30 of 134) with videos related to

Sort By:
Pageof 14
BJU International|April 18, 2015
Patients not P valuesJonathan Rees
The Practitioner|March 3, 2015
DRE has vital role in early detection of prostate cancerJonathan Rees
The Practitioner|October 12, 2017
Does testosterone therapy raise the risk of VTE?Jonathan Rees
The Practitioner|October 11, 2017
Active monitoring vs treatment for localised prostate cancerJonathan Rees
Plos Medicine|April 21, 2005
The problem with academic medicine: engineering our way into and out of the messJonathan Rees
The Practitioner|November 24, 2015
Androgen deprivation therapy and cardiovascular riskJonathan Rees
Lancet (London, England)|September 21, 2002
Functional polymorphism in EGF gene and malignant melanomaJonathan Rees
The Practitioner|August 3, 2013
No place for routine urine cytology in haematuriaJonathan Rees
The Practitioner|January 22, 2015
Obesity, metformin and prostate cancer riskJonathan Rees
The Practitioner|January 4, 2014
PSA in men in their 40s predicts risk of prostate cancer deathJonathan Rees
Pageof 14